Implications of Procalcitonin Testing in Critically Ill Patients with Sepsis

Affiliations

Comment

Jessica Nelson et al. Am J Respir Crit Care Med. 2019.

. 2019 Jan 15;199(2):232-234.

doi: 10.1164/rccm.201712-2544RR.

Erratum in

Erratum: Implications of Procalcitonin Testing in Critically Ill Patients with Sepsis.
[No authors listed] [No authors listed] Am J Respir Crit Care Med. 2019 Mar 1;199(5):669. doi: 10.1164/rccm.v199erratum1. Am J Respir Crit Care Med. 2019. PMID: 30821476 No abstract available.

No abstract available

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW. de Jong E, et al. Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2. Lancet Infect Dis. 2016. PMID: 26947523 Clinical Trial.
Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.
Balk RA, Kadri SS, Cao Z, Robinson SB, Lipkin C, Bozzette SA. Balk RA, et al. Chest. 2017 Jan;151(1):23-33. doi: 10.1016/j.chest.2016.06.046. Epub 2016 Aug 25. Chest. 2017. PMID: 27568580 Free PMC article.
Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.
Schuetz P, Birkhahn R, Sherwin R, Jones AE, Singer A, Kline JA, Runyon MS, Self WH, Courtney DM, Nowak RM, Gaieski DF, Ebmeyer S, Johannes S, Wiemer JC, Schwabe A, Shapiro NI. Schuetz P, et al. Crit Care Med. 2017 May;45(5):781-789. doi: 10.1097/CCM.0000000000002321. Crit Care Med. 2017. PMID: 28257335 Free PMC article.